Levothyroxine Recall: Thyro-Tabs 150mcg
Announced 2026-01-21 · FDA
A recall has been issued for Thyro-Tabs Levothyroxine Sodium Tablets, 150 mcg, 1000 tablets, Rx only. A single bottle of this lot reportedly contained 88 mcg tablets instead of 150 mcg due to a product mix-up. The recalled lot is Lot MHA21825 with expiration date December 31, 2027, distributed nationwide in the US.
| Brand | Alvogen, Inc |
|---|---|
| Product | Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10. |
| Reason | Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets. |
| Severity | moderate |
| Distribution | US Nationwide. |
| Agency | FDA |
| Recall / campaign no. | Lot # MHA21825, Exp Date: December 31, 2027 |
WHAT YOU SHOULD DO
- Do not use any tablets from Lot MHA21825.
- Contact your pharmacist or healthcare provider about replacement or refund.
- Return the product to the pharmacy or distributor as instructed.
- If you have questions or experience symptoms, seek medical advice.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.